These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 21810161

  • 1. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
    Abdollah F, Sun M, Jeldres C, Schmitges J, Thuret R, Djahangirian O, Tian Z, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI.
    BJU Int; 2012 Feb; 109(4):564-9. PubMed ID: 21810161
    [Abstract] [Full Text] [Related]

  • 2. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
    Lughezzani G, Sun M, Jeldres C, Alasker A, Budäus L, Shariat SF, Latour M, Widmer H, Duclos A, Jolivet-Tremblay M, Montorsi F, Perrotte P, Karakiewicz PI.
    Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091
    [Abstract] [Full Text] [Related]

  • 3. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
    Abdollah F, Sun M, Schmitges J, Djahangirian O, Tian Z, Jeldres C, Perrotte P, Shariat SF, Montorsi F, Karakiewicz PI.
    BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
    [Abstract] [Full Text] [Related]

  • 4. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
    Turker P, Bostrom PJ, Wroclawski ML, van Rhijn B, Kortekangas H, Kuk C, Mirtti T, Fleshner NE, Jewett MA, Finelli A, Kwast TV, Evans A, Sweet J, Laato M, Zlotta AR.
    BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341
    [Abstract] [Full Text] [Related]

  • 5. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
    Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budäus L, Latour M, Widmer H, Duclos A, Bénard F, McCormack M, Montorsi F, Karakiewicz PI.
    Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
    [Abstract] [Full Text] [Related]

  • 6. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Alasker A, Pharand D, Widmer H, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [Abstract] [Full Text] [Related]

  • 7. Marital status: a gender-independent risk factor for poorer survival after radical cystectomy.
    Sammon JD, Morgan M, Djahangirian O, Trinh QD, Sun M, Ghani KR, Jeong W, Jhaveri J, Ehlert M, Schmitges J, Bianchi M, Shariat SF, Perrotte P, Rogers CG, Peabody JO, Menon M, Karakiewicz PI.
    BJU Int; 2012 Nov; 110(9):1301-9. PubMed ID: 22449122
    [Abstract] [Full Text] [Related]

  • 8. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    Wright JL, Black PC, Brown GA, Porter MP, Kamat AM, Dinney CP, Lin DW.
    J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
    [Abstract] [Full Text] [Related]

  • 9. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 10. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A, Green DA, Kluth LA, Pycha A, Fradet Y, Faison T, Lee RK, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF.
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [Abstract] [Full Text] [Related]

  • 11. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 May; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 12. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, Lerner SP, Schoenberg MP.
    J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [Abstract] [Full Text] [Related]

  • 14. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy.
    Nielsen ME, Shariat SF, Karakiewicz PI, Lotan Y, Rogers CG, Amiel GE, Bastian PJ, Vazina A, Gupta A, Lerner SP, Sagalowsky AI, Schoenberg MP, Palapattu GS, Bladder Cancer Research Consortium (BCRC).
    Eur Urol; 2007 Mar; 51(3):699-706; discussion 706-8. PubMed ID: 17113703
    [Abstract] [Full Text] [Related]

  • 15. A population based assessment of perioperative mortality after cystectomy for bladder cancer.
    Isbarn H, Jeldres C, Zini L, Perrotte P, Baillargeon-Gagne S, Capitanio U, Shariat SF, Arjane P, Saad F, McCormack M, Valiquette L, Peloquin F, Duclos A, Montorsi F, Graefen M, Karakiewicz PI.
    J Urol; 2009 Jul; 182(1):70-7. PubMed ID: 19447427
    [Abstract] [Full Text] [Related]

  • 16. The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis.
    Rosiello G, Palumbo C, Pecoraro A, Luzzago S, Deuker M, Stolzenbach LF, Tian Z, Gallina A, Gandaglia G, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.
    Urol Oncol; 2021 Apr; 39(4):236.e1-236.e7. PubMed ID: 33036900
    [Abstract] [Full Text] [Related]

  • 17. Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.
    Capitanio U, Isbarn H, Shariat SF, Jeldres C, Zini L, Saad F, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    Urology; 2009 Oct; 74(4):858-64. PubMed ID: 19628260
    [Abstract] [Full Text] [Related]

  • 18. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y.
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [Abstract] [Full Text] [Related]

  • 19. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?
    Scosyrev E, Yao J, Messing E.
    Urology; 2009 Apr; 73(4):822-7. PubMed ID: 19193403
    [Abstract] [Full Text] [Related]

  • 20. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, Boorjian SA.
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.